ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bellerophon Announces Closing of $7 Million Public Offering of Common Stock
January 28, 2019Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today announced the closing and funding of its previously announced underwritten public offering of 10,000,000 shares of its common s
Pharma Sources Insight January 2025
